Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,918 | 414 | 98.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $158.66 | 7 | 1.4% |
| Education | $27.64 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $2,007 | 69 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $770.24 | 34 | $0 (2021) |
| ABBVIE INC. | $717.05 | 38 | $0 (2024) |
| SK Life Science, Inc. | $691.27 | 17 | $0 (2024) |
| CATALYST PHARMACEUTICALS, INC. | $667.60 | 16 | $0 (2024) |
| Eisai Inc. | $529.62 | 16 | $0 (2024) |
| GE HEALTHCARE | $413.26 | 15 | $0 (2024) |
| NEUROPACE, INC. | $382.45 | 3 | $0 (2024) |
| Amgen Inc. | $310.31 | 16 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $306.69 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,726 | 98 | CATALYST PHARMACEUTICALS, INC. ($597.92) |
| 2023 | $2,100 | 79 | UCB, Inc. ($826.02) |
| 2022 | $1,259 | 54 | Neurelis, Inc. ($119.59) |
| 2021 | $1,028 | 31 | SK Life Science, Inc. ($241.93) |
| 2020 | $1,181 | 47 | SK Life Science, Inc. ($264.69) |
| 2019 | $1,382 | 77 | UCB, Inc. ($193.52) |
| 2018 | $570.93 | 19 | PORTOLA PHARMACEUTICALS, INC. ($157.16) |
| 2017 | $855.90 | 18 | Sunovion Pharmaceuticals Inc. ($335.00) |
All Payment Transactions
423 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Central Nervous System | ||||||
| 12/11/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $40.02 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $44.64 | General |
| Category: Neurology | ||||||
| 12/03/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $9.30 | General |
| Category: Neurology | ||||||
| 12/02/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/26/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $30.76 | General |
| Category: Immunology | ||||||
| 11/11/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: NEUROLOGY | ||||||
| 11/06/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $121.84 | General |
| Category: NEUROLOGY | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: Neurology | ||||||
| 11/04/2024 | ARGENX US, INC. | VYVGART (Drug), VYVGART HYTRULO | Food and Beverage | In-kind items and services | $31.07 | General |
| Category: Immunology | ||||||
| 10/31/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $28.52 | General |
| 10/31/2024 | ABBVIE INC. | VYALEV (Drug), DUOPA | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: PAIN | ||||||
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Adenosine A2A Receptors | ||||||
| 10/21/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: EPILEPSY | ||||||
| 10/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: Neurology | ||||||
| 10/16/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Neurology | ||||||
| 10/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: NEUROLOGY | ||||||
| 09/25/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $31.09 | General |
| 09/24/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Food and Beverage | In-kind items and services | $132.08 | General |
| Category: Epilepsy | ||||||
| 09/23/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,005 | 1,182 | $265,287 | $102,654 |
| 2022 | 15 | 982 | 1,130 | $274,220 | $102,636 |
| 2021 | 12 | 720 | 884 | $260,004 | $86,215 |
| 2020 | 17 | 705 | 830 | $166,328 | $70,046 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 231 | 236 | $66,788 | $24,022 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 256 | 370 | $55,870 | $22,934 | 41.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 148 | 194 | $41,322 | $18,271 | 44.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 81 | 81 | $33,615 | $10,575 | 31.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 46 | $13,524 | $6,006 | 44.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 92 | 94 | $11,092 | $4,059 | 36.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $10,989 | $4,050 | 36.9% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 17 | 25 | $10,700 | $4,021 | 37.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 37 | $8,103 | $3,557 | 43.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 19 | 19 | $7,999 | $3,156 | 39.5% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 36 | 36 | $4,284 | $1,565 | 36.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $1,001 | $438.80 | 43.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 191 | 244 | $53,676 | $19,624 | 36.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 168 | 171 | $49,237 | $17,842 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 166 | 247 | $37,297 | $15,559 | 41.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 89 | 90 | $37,350 | $13,407 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $19,647 | $6,774 | 34.5% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 48 | 48 | $18,192 | $6,651 | 36.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 38 | $11,172 | $4,875 | 43.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $10,946 | $3,935 | 35.9% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 12 | 22 | $9,416 | $3,639 | 38.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 83 | 83 | $9,794 | $3,560 | 36.4% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 23 | 23 | $6,394 | $2,422 | 37.9% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 36 | 36 | $4,284 | $1,635 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 12 | $2,628 | $1,209 | 46.0% |
About Dr. Brian Wolf, MD
Dr. Brian Wolf, MD is a Neurology healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2015. The National Provider Identifier (NPI) number assigned to this provider is 1407247307.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Wolf, MD has received a total of $11,104 in payments from pharmaceutical and medical device companies, with $2,726 received in 2024. These payments were reported across 423 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($10,918).
As a Medicare-enrolled provider, Wolf has provided services to 3,412 Medicare beneficiaries, totaling 4,026 services with total Medicare billing of $361,550. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Sarasota, FL
- Active Since 02/12/2015
- Last Updated 03/31/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1407247307
Products in Payments
- Briviact (Drug) $910.73
- APTIOM (Drug) $692.42
- FYCOMPA (Drug) $565.52
- Fycompa (Drug) $423.44
- NURTEC ODT (Drug) $331.97
- Aimovig (Biological) $310.31
- Fintepla (Drug) $307.57
- Nayzilam (Drug) $303.96
- QULIPTA (Drug) $258.37
- RNS System (Device) $250.37
- INGREZZA (Drug) $236.00
- XCOPRI (Drug) $230.75
- Epidiolex (Drug) $222.19
- INBRIJA (Drug) $208.17
- VALTOCO (Drug) $207.87
- BOTOX (Biological) $205.82
- UBRELVY (Drug) $199.89
- GOCOVRI (Drug) $192.15
- Vimpat (Drug) $185.51
- AIMOVIG (Biological) $176.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Sarasota
Donald Negroski, Md, MD
Neurology — Payments: $1.8M
Dr. V Kassicieh, D.o, D.O
Neurology — Payments: $403,795
Mauricio Concha, Md, MD
Neurology — Payments: $274,642
Gregory Hanes, Md, MD
Neurology — Payments: $261,651
Ricardo Gonzalez, Md, MD
Neurology — Payments: $74,673
Dean Sutherland, Md, MD
Neurology — Payments: $67,914